Unleashing American Innovation: Return on Investment Initiative and Next Steps
Part of the Technology Transfer and Innovation Forum Series
of the Washington, DC Chapter of the Technology Transfer Forum, presents:
"Unleashing American Innovation: Return on Investment Initiative and Next Steps"
Free admission but please register at https://t2sdcforum9-8.eventbrite.com
Remote access option is available; information will be sent to those who register.
The Topic: In 2018, NIST launched the Return on Investment (ROI) Initiative, a broad stakeholder engagement process to collect information on needed improvements in federal technology transfer. The ROI Initiative supports the President’s Management Agenda by informing the Lab-to-Market Cross Agency Priority goal and the National Science and Technology Council’s Lab-to-Market subcommittee. The NIST ROI initiative culminated in the publication of a final green paper, NIST Special Publication 1234 “Return on Investment Initiative to Advance the President’s Management Agenda” in April 2019. Here, the ROI Initiative process, findings, and next steps are reviewed.
The Speaker: Dr. Courtney Silverthorn is the Deputy Director of the Technology Partnerships Office at NIST, focusing on cross-agency technology transfer policy efforts and the implementation of the White House's Lab-to-Market Cross Agency Priority goal, as well as overseeing NIST-centric and agency-wide economic analysis on the impact of federal technology transfer. She is the Executive Secretariat for the National Science and Technology Council’s Lab-to-Market subcommittee and coordinates several Interagency working groups for tech transfer and intellectual property issues. Courtney joined TPO in 2014 as a Senior Interagency Policy Specialist. Prior to coming to NIST, she held tech transfer and partnership development roles at the Frederick National Laboratory for Cancer Research and the National Cancer Institute. She serves on the FLC's Executive Board as the Finance Officer, and previously held roles as the Host Agency Representative, Mid-Atlantic Regional Coordinator and Deputy Regional Coordinator. Dr. Silverthorn earned a Ph.D. in Pharmacology from The Johns Hopkins University School of Medicine and a B.S. in Biochemistry and Molecular Biology from Sweet Briar College; certificates in Biotechnology Enterprise from Johns Hopkins and in Policy Strategy from the Brookings Institution, and is pursuing a Masters in Leadership and Policy fromWashington University in St. Louis.